YourChoice Therapeutics is a startup based in the United States, 1 tracked investor.
YourChoice Therapeutics is a startup based in the United States. Brouky records 1 investor associated with the company.
YourChoice Therapeutics is developing YCT-529, a selective retinoic acid receptor-alpha antagonist as an oral, non-hormonal male contraceptive currently in Phase 2 clinical trials.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.